|
|
|
|
|
You have been invited to attend!
The Impact of Minimal Residual Disease in Cancer
Featuring industry leaders
|
|
Thursday, May 20 • 7:00pm ET
|
|
|
Webinar Objectives:
- Review the role of MRD detection in GI cancer
- Explore how the role of MRD is evolving and how this will inform physicians in the future
- Discuss the potential impact MRD monitoring and detection has on patients
|
|
|
|
|
|
|
Tanios Bekaii-Saab, MD
Professor , Mayo Clinic College of Medicine and Science
Program Leader , Gastrointestinal Cancer, Mayo Clinic Cancer Center
Consultant , Mayo Clinic AZ , USA
Consortium Chair , ACCRU
Phoenix, AZ
|
|
|
|
Axel Grothey, MD
Director, GI Cancer Research
West Cancer Center and Research Institute
Germantown, TN
|
|
|
|
Manju George, MVSc PhD
Scientific Director
PALTOWN Development Foundation/COLONTOWN
Patient Advocate,
NCI Rectal Anal Task Force
Omaha, NE
|
|
|
|
|
|
|
|
|
